164. 眼皮膚白皮症 Oculocutaneous albinism Clinical trials / Disease details

臨床試験数 : 15 / 薬物数 : 57 - (DrugBank : 34) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 139

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04193592 (ClinicalTrials.gov)	December 1, 2019	6/11/2019	Efficacy and Safety of Pirfenidone Treatment in HPS-ILD	Pirfenidonein the Treatment of Hermansky Pudlak Syndrome (HPS) - Related Interstitial Lung Disease ( ...	Hermansky Pudlak Syndrome;Interstitial Lung Disease	Drug: Pirfenidone	Jesse Roman	Genentech, Inc.	Not yet recruiting	18 Years	75 Years	All	50	Phase 2	United States;Puerto Rico
2	NCT00001596 (ClinicalTrials.gov)	September 2005	3/11/1999	Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome	Therapeutic Clinical Trial of Oral Pirfenidonefor the Pulmonary Fibrosis of Hermansky-Pudlak Syndrom ...	Albinism;Inborn Errors of Metabolism;Oculocutaneous Albinism;Platelet Storage Pool Deficiency;Pulmon ...	Drug: Pirfenidone;Drug: Placebo	William Gahl, M.D.	National Human Genome Research Institute (NHGRI)	Completed	18 Years	N/A	All	35	Phase 2	United States;Puerto Rico

First Previous1Next Last